Neoagarooligosaccharide Protects against Hepatic Fibrosis via Inhibition of TGF-β/Smad Signaling Pathway

Hepatic fibrosis occurs when liver tissue becomes scarred from repetitive liver injury and inflammatory responses; it can progress to cirrhosis and eventually to hepatocellular carcinoma. Previously, we reported that neoagarooligosaccharides (NAOs), produced by the hydrolysis of agar by β-agarases,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ji Hye, Ku, Sae Kwang, Cho, IL Je, Lee, Je Hyeon, Na, Chang-Su, Ki, Sung Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922480/
https://www.ncbi.nlm.nih.gov/pubmed/33670808
http://dx.doi.org/10.3390/ijms22042041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922480/
https://www.ncbi.nlm.nih.gov/pubmed/33670808
http://dx.doi.org/10.3390/ijms22042041

Ejemplares similares